摘要
聚乙烯亚胺(PEI)是一种阳离子聚合物,被广泛作为非病毒基因载体使用;然而,由于其细胞毒性限制它的广泛应用。PEI既可以是分枝构型也可以是线性构型。然而,分枝型聚乙烯亚胺(bPEI)具有更好地化学活性且在含盐条件下能够与DNA聚合形成更小的复合物,线性聚乙烯亚胺(lPEI)通常毒性更低且具有更高的转染效率。本文,我们将低分子量的lPEI与甲基-β-环糊精交联生成甲基-β-环糊精-线性聚乙烯亚胺(MLP)。并成功地通过NMR、FT-IR、MALDI-TOF和元素分析鉴定了MLP的结构。在标准血清转染环境下,MLP能够有效地使转染胶质母细胞瘤、黑色素瘤和肝癌细胞。其在血清中维持了一个高的转染率。除了其高的转染率,还发现MLP在不同的浓度范围内都表现出及其微小的细胞毒性,同时表现了低的离体细胞膜破坏能力。在未来的研究中MLP将成为一个有前景的基因投递系统。
关键词: 癌症,环糊精,基因投递,基因疗法,非病毒基因载体,聚乙烯亚胺
Current Gene Therapy
Title:Linear Poly(ethylenimine) Cross-Linked by Methyl-β-Cyclodextrin for Gene Delivery
Volume: 14 Issue: 4
Author(s): Wing-Fu Lai, David W. Green and Han-Sung Jung
Affiliation:
关键词: 癌症,环糊精,基因投递,基因疗法,非病毒基因载体,聚乙烯亚胺
摘要: Poly(ethylenimine) (PEI) is a cationic polymer extensively exploited for non-viral gene delivery; however, its wide application has been impeded by its cytotoxicity. PEI can assume either a branched or linear configuration. Whereas branched PEI (bPEI) is more chemically reactive and can form smaller complexes with DNA under salt-containing conditions, lPEI is generally less toxic and exhibits higher transfection efficiency. In this study, we cross-linked low-molecularweight lPEI with methyl β-cyclodextrin (MβCD) to form MβCD-lPEI (MLP). The structure of MLP was successfully characterized by NMR, FT-IR, MALDI-TOF and elemental analysis. In the standard serum-free transfection environment, MLP could effectively transfect glioblastoma, melanoma and hepatocarcinoma cells. A high transfection efficiency was maintained in the presence of serum. Apart from its high transfection efficiency, MLP was found to have negligible cytotoxicity over a wide range of concentrations and to exhibit a low membrane disruptive capacity ex vivo. MLP warrants further development as a promising gene delivery system for future research.
Export Options
About this article
Cite this article as:
Lai Wing-Fu, Green W. David and Jung Han-Sung, Linear Poly(ethylenimine) Cross-Linked by Methyl-β-Cyclodextrin for Gene Delivery, Current Gene Therapy 2014; 14 (4) . https://dx.doi.org/10.2174/1566523214666140612160042
DOI https://dx.doi.org/10.2174/1566523214666140612160042 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ipilimumab Targeting CD28-CTLA-4 Axis: New Hope in the Treatment of Melanoma
Current Topics in Medicinal Chemistry Microbicides for Prevention of Transmission of Sexually Transmitted Diseases
Current Pharmaceutical Design Prerequisite of a Holistic Blend of Traditional and Modern Approaches of Cancer Management
Current Cancer Therapy Reviews Targeting Angiogenic Pathways in Colorectal Cancer: Complexities, Challenges and Future Directions
Current Drug Targets The Detrimental Effect of Smoking on Female Fertility and IVF Success
Current Women`s Health Reviews New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Current Cancer Drug Targets Effect of Drugs in Cells and Tissues by NMR Spectroscopy
Current Topics in Medicinal Chemistry Long Term Cardiovascular Risk in Women
Vascular Disease Prevention (Discontinued) Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer
Current Cancer Drug Targets Investigating the In Vivo Expression Patterns of miR-7 microRNA Family Members in the Adult Mouse Brain
MicroRNA Influence of Leptin on Immunity
Current Immunology Reviews (Discontinued) Extracellular SH3 Domain Containing Proteins – Features of a New Protein Family
Current Protein & Peptide Science MicroRNA-34 Family, Mechanisms of Action in Cancer: A Review
Current Cancer Drug Targets Discovery of New Biomarkers of Cancer Using Proteomics Technology
Current Cancer Therapy Reviews Ruthenium Nanoparticles in Ionic Liquids – A Saga
Current Organic Chemistry The Role of miRNAs in Plasma Cell Dyscrasias
MicroRNA Immunotherapy in Gastric Carcinoma: Current Status and Future Perspectives
Clinical Cancer Drugs Antibodies as Crypts of Antiinfective and Antitumor Peptides
Current Medicinal Chemistry Activin Receptor-Like Kinases: Structure, Function and Clinical Implications
Endocrine, Metabolic & Immune Disorders - Drug Targets Data Science Approaches to Pharmacogenetics
Current Molecular Medicine